Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study of Nasal PYY3-36 and Placebo for Weight Loss in Obese Subjects
This study has been completed.
Study NCT00537420.   Last updated on September 12, 2008.
Information provided by Nastech Pharmaceutical Company, Inc.
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Obesity
Additional conditions recognized in this trial
Weight Loss
More general conditions related to this trial
Body Weight
Body Weight Changes
Nutrition Disorders
Overnutrition
Overweight
Signs and Symptoms
Interventions listed in this trial
Nasal Placebo
Placebo Capsule
PYY3-36
Sibutramine
More general drug interventions related to this trial
Anti-Obesity Agents
Antidepressive Agents
Appetite Depressants
Central Nervous System Agents
Pharmacologic Actions
Psychotropic Drugs
Therapeutic Uses
Sponsors listed in this trial
Nastech Pharmaceutical Company, Inc.


U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services